Skip to main content Skip to section navigation Skip to footer
Careers
Codexis, Inc. Corporate Page
  • About Us
    • Overview
    • Culture
    • Our People
    • Management Team
    • Board of Directors
    • Strategic Advisory Board
    • Sustainability
  • Services
    • Overview
    • Pharmaceutical Biocatalysis
    • RNA Manufacturing
  • Technology
    • CodeEvolver® Platform
    • ECO Synthesis™ Technology
  • Technical Content
  • Newsroom
    • Overview
    • In The News
    • Media Assets
  • Investors
    • Overview
    • News & Events
    • Presentations
    • Company Info
    • Financial Info
    • Stock Data
    • SEC Filings
    • Corporate Governance
  • Contact
  • chevron_leftCareers

Access our TIDES USA 2025 Investor Recap Call

View Replay

Press Releases

Investors

Investors

  • Overview
  • News & Events
    • Overview
    • Press Releases
    • IR Calendar
    • Email Alerts
    • TIDES US
  • Presentations
  • Company Info
    • Overview
    • Management Team
    • Contacts
    • FAQ
  • Financial Info
    • Overview
    • Financial Results
    • Income Statement
    • Balance Sheet
    • Cash Flow
  • Stock Data
    • Quote and Chart
    • Historical Data
    • Analyst Coverage
  • SEC Filings
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Corporate Governance
    • At-a-Glance
    • Board of Directors
    • Board Committees
    • Governance Documents
    • Codexis Ethics Helpline
  • News & Events

  • Overview
  • Press Releases
  • IR Calendar
  • Email Alerts
  • TIDES US
Jul 30, 2019 7:00 am EDT
Codexis to Hold Second Quarter 2019 Conference Call on August 6
Read More
Jun 20, 2019 7:00 am EDT
Casdin Capital Invests $50 Million in Codexis to Accelerate Strategic Growth Initiatives
Read More
May 30, 2019 7:00 am EDT
Codexis to Present at the Jefferies 2019 Global Healthcare Conference
Read More
May 15, 2019 9:00 am EDT
Codexis Announces CodeEvolver® Technology Transfer and License Agreement with Global Pharmaceutical Leader
Read More
May 14, 2019 4:05 pm EDT
Codexis to Participate at Three Investment Conferences in May
Read More
May 6, 2019 4:06 pm EDT
Codexis Reports First Quarter 2019 Financial Results
Read More
Apr 30, 2019 7:00 am EDT
Codexis Signs Multi-Year Enzyme Supply and Licensing Agreement with Tate & Lyle for the Manufacture of TASTEVA® M Stevia Sweetener
Read More
Apr 29, 2019 7:00 am EDT
Codexis to Hold First Quarter 2019 Conference Call on May 6
Read More
Apr 5, 2019 4:05 pm EDT
Codexis Senior Vice President of R&D Dr. Jim Lalonde Announces Plan to Resign
Read More
Mar 5, 2019 7:00 am EST
Codexis to Participate in Two Investment Conferences in March
Read More
  • Previous Pagechevron_left
  • Page 1
  • …
  • Page 14
  • Page 15
  • Page 16
  • Page 17
  • Page 18
  • Page 19
  • Page 20
  • Page 21
  • Page 22
  • Page 23
  • …
  • Page 26
  • Next Pagechevron_right
rss_feed News RSS
  • emailEmail Alerts
  • location_cityCompany Profile
  • contact_pageContacts
  • rss_feedRSS News Feed

Headquarters

200 Penobscot Drive
Redwood City, California
94063

Contact Us

©2025 Codexis, Inc. All Rights Reserved.
  • Sitemap
  • Terms of Sale
  • Trademarks
  • Terms of Use
  • Privacy
  • Accessibility Statement
  • Disclaimer
  • Patents
  • Events
  • Careers